Pulmonary resistance and maximal expiratory flowrate following isoprenaline in patients with chronic obstructive lung disease.
D000328:Adult; D000336:Aerosols; D000368:Aged; D000403:Airway Resistance / Q000187:drug effects; D006801:Humans; D007545:Isoproterenol / Q000494:pharmacology / Q000627:therapeutic use*; D008168:Lung / Q000187:drug effects / Q000503:physiopathology; D008170:Lung Compliance / Q000187:drug effects; D008173:Lung Diseases, Obstructive / Q000188:drug therapy* / Q000503:physiopathology; D008875:Middle Aged; D012123:Pulmonary Ventilation / Q000187:drug effects; D013147:Spirometry; D014797:Vital Capacity / Q000187:drug effects
D000336:Aerosols; D007545:Isoproterenol